ARIAD PHARMACEUTICALS INC·4

Mar 20, 4:42 PM ET

Keane Raymond T 4

4 · ARIAD PHARMACEUTICALS INC · Filed Mar 20, 2013

Insider Transaction Report

Form 4
Period: 2013-03-19
Keane Raymond T
SVP General Counsel & CCO
Transactions
  • Award

    Restricted Stock Units

    2013-03-19+14,25014,250 total
    Exp: 2023-03-19Common Stock (14,250 underlying)
  • Award

    Employee Stock Option (Right to Buy)

    2013-03-19+28,50028,500 total
    Exercise: $20.89Exp: 2023-03-19Common Stock (28,500 underlying)
Footnotes (3)
  • [F1]Options vest as to 33-1/3% of the award on each of March 19, 2014, March 19, 2015 and March 19, 2016
  • [F2]Each restricted stock unit represents a right to receive one share of ARIAD common stock.
  • [F3]Restricted Stock Units vest as to 33-1/3% of the award on each of March 19, 2014, March 19, 2015 and March 19, 2016

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT